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CHAPTER I
INTRODUCTION
Orr et al. (43) were among the first to suggest that a defective
absorption of calcium and phosphate from the intestine, with a concomitant loss in the feces, was the result of vitamin D deficiency.

Upon

further investigation, Gyorgy (22) and Harris (24) concluded that this
excessive loss of calcium in the fecal matter of vitamin D deficient
animals was not due to faulty absorption, but rather to excessive excretion of calcium into the large intestine.

Nicolaysen (36, 37) and

Nicolaysen et al. (38) clarified thi& point by demonstrating conclusively
that vitamin D increases the absorption of calcium and, secondarily,
that of phosphorus in the small intestine, and that the effects of vitamin
D could not be due to reduced excretion of calcium into the small
intestine.

Absorption of phosphate appeared to take place equally well

in the absence and in the presence of vitamin D.

Since 19 53 various

reviews on the intestinal absorption of calcium and concerned with many
factors of influence including vitamin D have been published.
formation is available in a book edited by Wasserman (60).

This inThere is

little doubt that one of the basic physiological effects of vitamin D is to
stimulate the absorption of calcium from the small intestine and,
secondarily, that of phosphate.
The overwhelming evidence implicating vitamin D in the intestinal

~··
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ab so "ption of calcium has promoted much research in an attempt to
eluci ;late the mechanism of action of vitamin D on this absorption
procE ss.

The everted gut sac technique of Schachter et al. (51) is the

--

in vitro -experimental procedure utilized in studying the role of vitamin
It involves taking a strip of intestine and

D in calcium absorption.

turning it inside out so that the mucosal surface is now on the outside
and the serosal surface is on the inside; then one or both ends of the
intestinal strip are tied.

This simulates the condition whereby the

I

I
I

fluid bathing the mucosa! surface would represent that existing in the
lumen of the intestine.

By adding equal concentrations of calcium to

both sides of the sac, the rate of uptake of calcium by the sac can be
established by determining the ratio of serosal calcium/mucosal calcium

·
t·lme m
· t erva1s.
at various

· t opes
T h e ra d'l01so

45

ca

to establish the rate of uptake of the calcium ion.

an d

47

Ca are use d

Using this technique

and the rat as the test animal, Schachter et al. ( 50) were able to
demonstrate that calcium transport occurred against a concentration as
well as an electrochemical gradient, and that this process was enha_nced
by prior administration of vitamin D ; addition of the vitamin directly to
2
the test medium had no effect.

It might be added here that Wasserman

.et al. ( 63) also showed with in vivo· studies that calcium absorption
occurred against concentration and electrochemical gradients.

Schachter

- 3 -

et

~-

(50) also found with in vitro studies that calcium transport de-

creard as the distance from the pylorus increased, and that metabolic
inhib.itors or a nitrogen atmosphere blocked the active transport of
I

calcium by intestine.

It was then suggested by Schachter et al. (49}

that the uptake of calcium at the mucosal surface may be facilitated
diffusion, and that its transport to the serosal side was dependent upon
oxidative metabolism and the generation of phosphate bond energy.

This

two step process was confined primarily to the duodenum and was
I

vitamin D dependent.
That metabolic inhibitors oan blo.ck the active transport of calcium
by intestine might be expected.

However, the question arose whether

the action of vitamin D itself was blocked.

Schachter and co-workers

(49, 50,. 51} employed techniques which measured active transport but in
no way affected the activity of vitamin D on the permeability of intestine
to calcium.

With in vitro techniques Harrison et al. (25} demonstrated

that the transport of calcium across the intestine involves two processes:
(a} penetration of the diffusion barrier of mucosal epithelium, and (b}
the active transport of calcium across the mucosal cell; both of these
processes were most active in the duodenal portion of the small
intestine.

Prior administration of vitamin D to animals a few hours

before the intestinal preparations were made significantly influenced the

#
- 4 first step by reducing the diffusion barrier to calcium.

They concluded

that the primary action of the vitamin is to increase the permeability of
intestine to calcium making it available to the active transport system.
The in vivo experiments of Wasserman et al. (62. 64} showed that

---

--

vitamin D increases the passage of calcium from intestinal lumen to
blood and from blood to the lumen.

From their work. they concluded

that a specific effect of vitamin D on a unidirectionally oriented active
transport is not entirely correct.

The exact nature of the permeability

change resulting from vitamin D action may be an alteration in
membrane structure of mucosal cells .and/or an increased synthesis of
a "carrier" substance which enhances the movement of calcium in both
directions.
There is also evidence that vitamin D alters the permeability of
subcellular membranes to calcium (12).

Calcium is actively taken up by

mitochondria and vitamin D has no effect on this process.

However.

when the release of this calcium by the mitochondria is examined.
vitamin D has a marked stimulatory effect whether it is given in vivo
or in vitro.

The stimulation of calcium release from mitochondria has

been interpreted as an effect of vitamin D on membrane permeability to
calcium.

Microsomal preparations ·from chick intestinal mucosa bind

calcium in vitro and the ?indiz:ig is depressed by addition of vitamin D.

a;
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The apparent depressed-binding could have been a consequence of increased release.

All of these effects were found relatively specific for

the vitamin D molecule and. for calcium and appear to be in harmony
with those of Harrison et al. {25) regarding intestinal permeability.
More recently. Haskim et al. {27) demonstrated with the use of mucosal
cell suspensions that vitamin D is involved in the release of calcium
rather than in its uptake by mucosal cells.

Although the exact site of

accumulation of calcium within the epithelial cells was not determined,
they suggested from their study that vitamin D could possibly prevent
intracellular accumulation of calcium by increasing the membrane permeability of subcellular particles as well as the cellular membrane itself.
An interesting hypothesis proposed by Zull et al. {67) suggests a

--

mechanism whereby vitamin D may alter calcium binding by membrane
systems.

It has been suggested frequently in the past that phospho-

lipids bind calcium and other divalent cations at the surface of cell
membranes.

Using vitamin D and egg lecithin as a model system,

these investigators studied the interaction of the vitamin and phospholipid and found that such an interaction would have the effect of displacing ions bound to the phospholipid.

The net result in a cell

membrane would be reduced binding of divalent cations such as calcium.
In the presence of excess~ vital!lin D then, such an effect would produce

- 6 a si nificant alteration in calcium binding by the cell membranes and
poss bly prevent the intracellular accumulation of the cation.

If vitamin D alters intestinal permeability to calcium. is it
necessary to implicate vitamin D in some manner with the active transport mechanism?

In other words. can the action of vitamin D be ex-

plained solely on the basis of an alteration of intestinal permeability?
Evidence to the contrary arises because of a time lag between vitamin
D adm,inistration and its observed action.
doses of

3

For example, when small

H-vitamin D are given such as 10 I. U. (1 I. U.

=

O. 025 µg) to

a rat radioactivity can be detected in the intestinal mucosa in 1 - 3
hours. but the apparent active transport of calcium does not take place
until 10 - 12 hours later.

If an active transport system were preformed,

the response to vitamin D would appear much earlier than 10 hours.
Also. actinomycin D blocks or prevents all physiological responses to
vitamin D including active transport of calcium by intestine. whereas it
does not block the vitamin's action on intestinal permeability to calcium
(26, 66) .. Again, this would argue strongly against the idea that a transport system for calcium is totally preformed and all vitamin D does is
make available the calcium to be transported.
Eisenstein and Passavoy ( 19) first noted that actinomycin D. an
antibiotic which is known to block DNA transcription into RNA; blocks

.
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the hypercalcemic response to large doses of vitamin D.

Later it was

demonstrated that administration of actinomycin D prior to vitamin D
not only prevented a rise in serum calcium but also blocked the increased transport of calcium across everted gut sacs (39, 40, 65, 66).
This inhibition of vitamin D action was not due to a decrease in
absorption of the vitamin; an injected dose of vitamin D was no more
effective than an oral dose if the animal had been pretreated with
actinomycin D.

They also showed that the distribution of the vitamin

was not affected by actinomycin D, since the antibiotic did not block the
transport of vitamin D to small intestine, kidney, liver or bone in rats.
Also, inhibition by the antibiotic could not be attributed to a general
toxicity or cell necrosis, because photomicrographs of intestinal
epithelial cells obtained from normal and actinomycin D-treated rats
appeared to be identical in nature.

Of interest here is the fact that

the effect of actinomycin could be eliminated if vitamin D was administered to an animal 4 - 8 hours prior to the administration of the
antibiotic.

It would appear, therefore, that the antibiotic inhibits some

early event in the chain of events necessary to bring about the
physiological expression of vitamin D action.
More direct evidence that vitamin D acts on the chromatin
material has been

provid~d

by_ Hallick et al. (23).

Vitamin n was ad-

"!
- 8 -

,;.in~stered

to rats deficient in this vitamin and the intestinal mucosal

chroratin was isolated.
temp~ate

The isolated chromatin was then used as a

for DNA-directed RNA synthesis in an in vitro RNA-synthe-

sizing system.

Prior administration of vitamin D markedly increased

the template activity for DNA-dependent RNA synthesis by the rat
intestinal mucosal chromatin.
Pulse labeling experiments with

3

H-orotic acid and

3

H-uridine

have produced
additional evidence that vitamin D may act directly on the
I
DNA - m-RNA complex.

Stohs et al. (55) administered 2000 I. U. of

vitamin D to rats; this was followed at various time intervals by a dose
of

3

H-orotic acid·.

One hour after the administration of the tracer the

animals were sacrificed and various types of cellular RNA were isolated
from intestinal mucosal cells.
3

Vitamin D stimulated incorporation of

H-orotic acid into nuclear RNA but not ribosomal or mitochondrial

RNA within three hours; this effect was completely blocked by prior administration of actinomycin D.

Norman (41) has obtained similar

results upon showing that vitamin D stimulates the labeling of RNA .in
3H
. k s using
.
c h ic
-ur1.d.ine.

These data would imply that the expression of

vitamin D action on intestinal epithelium in some manner involves DNA
transcription into m-RNA and translation into functional protein( s).
The nature of the

inferac~ion

of vitamin D with the mucosal cell

- 9 -

has stimulated investigation on the subcellular localization of the vitamin.

Vitamin D, when administered to animals at physiological levels,

appears in high concentration as the vitamin or its metabolites associ'ated with the nuclear chromatin material or nuclear membrane (28, 29,
34, 52).

Upon isolation of the metabolites, in order to test for their

biological significance, it was found that the metabolite of highest concentration appeared to be the biologically active form of vitamin D (5).

This

compound has been identified as 25-hydroxycholecalciferol {3, 4, 7).

As

compared to vitamin

o 3 , it is mor; active biologically in rats and

chicks and acts more rapidly to induce bone mobilization and intestinal
transport of calcium.
as vitamin

o3

It also induces bone mobilization in vitro, where-

is only minimally effective in culture (58).

Whether the

nuclear interaction represents a direct effect of the metabolite on the
DNA - ·m-RNA complex or an indirect alteration of the permeability
characteristics of the nuclear membrane is not known.
Wasserman and co-workers (31,55,64) have reported the presence
of a vitamin D induced protein in intestine which will bind calcium ...
There is a close relation, in time of vitamin D administration, between
the appearance of this calcium-binding protein and the enhanced
absorption of calcium in vivo.

Purification of the protein has revealed

that its concentration in various
.
. soft tissues correlates well with their

µ:
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respective ability to respond physiologically to vitamin D (55, 61).

For

example. the calcium absorptive capacity of the small intestine decreases in the following order. duodenum> jejunum> ileum; subsequent
examination of the calcium-binding protein concentration in these
intestinal segments showed a similar decrease.

A preliminary analysis

of the composition of the protein has been reported (61).
From these data, Wasserman and co-workers proposed the hypothesis that the vitamin D induced calcium-binding protein is in some
manner intimately involved in the translocation of calcium across the
intestinal epithelial cell.

This would in part explain the lag period ob-

served between the time when vitamin D is administered and the time
when a physiological response can first be observed (48, 59).
Recently Martin et al. (35) have demonstrated that a calcium
dependent adenosine triphosphatase located in the brush borders of the
rat small intestine is markedly increased after the administration of
vitamin D to vitamin D deficient rats.

They propose that the increase

in enzyme activity stimulated by the vitamin may in some way be an

expression of vitamin D action on calcium transport resulting in the
transfer of calcium across the brush border surface of the columnar
epithelial cell.
At the present time ·it is evident that the calcium transport

p
- 11 process of the intestine, which is under the influence of vitamin D, cannot be attributed solely to active transport or to an increase in membrane permeability.

The vitamin participates in some fashion in an

active transport system, perhaps in the formation of it or some
component thereof.

It has, in addition, an effect on intestinal membrane

permeability to calcium.

Whether or not this is the primary event in

the action of the vitamin remains to be determined, although it is clear
that a mere increase in intestinal permeability to calcium cannot by itself account for the physiological effects of vitamin D.

Observations to

date appear to be consistent with the formation of a carrier protein
system for calcium induced by vitamin D as suggested by Wasserman
et al. (64).
In addition to the small intestine the physiological action of vitamin
D is directed toward bone where it acts by promoting accretion.

The

gross and light microscopic changes that occur in the calcification of
cartilage are well known.

However, the exact biochemical processes

underlying these changes are not fully understood.
The cartilage or epiphyseal disc of long bone consists of three
zones, each characterized by both the arrangement and size of the cell
(17).

The immature or resting cell zone is a narrow band in close

proximity to the epiphysis. of

t?e

bone.

The proliferating cell zone con-
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sist~ of larger cells arranged in longitudinal columns separated from
one rother by cartilaginous matrix.

The zone adjacent to the diaphysis

(bone, shaft) is the hypertrophic or mature cell zone and it is here that
'a line of calcification is observed in bone growth with subsequent disintegration of the cartilage cells.
In the course of endochondral calcification in the epiphyseal disc,
cartilage cells from the basal proliferating layers transform in an
I

orderly fashion into hypertrophic cells as the zone of calcification is
reached.

With growth and maturatipn of these hypertrophic cells, intra-

cellular glycogen appears to increase (20, 46).

In addition, phosphorylase

is present in those cells which have hypertrophied most recently ( 10).
Upon deposition of amorphous calcium phosphate in the ground substance
about these cells in the zone of calcification, there appears to be glycogenolysis prior to or concomitant with disintegration of the hypertrophic
cartilage cells ( 5 7).
In rickets produced in young rats by a low phosphate and vitamin
D-deficient diet, the epiphyseal plate is markedly thickened because of
widening and disorganization of the proliferating and hypertrophic cell
zones.·

The cartilage cells fail to mature and disintegrate or be

destroyed but instead continuously produce matrix material; this accounts
for the resultant overgrowth of cartilage . . Following administration of

p
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vitamin D to a rachitic animal, a line of calcification is observed in
the hypertrophic cell zone (18).

In addition, a decrease in glycogen

stainability was demonstrated in these cells ( 46), and this effect has
been observed as early as 48 hours in rachitic rat cartilage following
vitamin D administration (16).

From these data it would appear that

vitamin D has some effect on glycolysis, and that anaerobic metabolism
and the calcification of cartilage are closely associated.
Changes in enzyme activity in the cartilage of the rachitic rat
and dog following vitamin D administration have been reported (15, 30).
Within 24 hours after vitamin D treatment citrate synthetase activity
was significantly elevated; this was accompanied by an increase in the
citrate content of the cartilage cells.

It was not determined whether the

vitamin acted directly upon the enzymatic reaction or indirectly by
affecting the synthesis of the synthetase.

In addition, the effect, if any,

that a measurable increase in citrate content would have on the calcification process could not be discerned.
Cartilage cells synthesize mucopolysaccharides; the polysaccharide
moiety of the molecule is composed of repeating disaccharide units of
glucuronic acid and a hexosamine.

These molecules are released by

cartilage cells into the intercellular space and become an integral part
of the ground substance necessary for cartilage calcification (6).

.

'

p
- 14 Following vitamin D administration, an elevation of hexosamine synthetase activity has been observed in rachitic cartilage ( 14).

Since

hexosamine is a component of the ground substance mucopolysaccharide,
it is apparent that any factor affecting its level in cartilage cells may
indirectly alter the calcification process.
Attempts to determine a characteristic pattern of enzymes in the
various layers of the epiphyseal disc of rachitic cartilage, following
vitamin D administration, have not been very rewarding.

Epiphyseal

cartilage is essentially avascular and the principal end product of
glucose metabolism is lactic acid (33)..

Nevertheless, oxidative

enzymes do exist in cartilage cells ( 1), since aerobic metabolism is
necessary for the synthesis of matrix material.

Upon vitamin D admin-

istration to D-deficient animals the activity of the oxidative enzyme
isocitric dehydrogenase in the hypertrophic cell zone decreased (2).
Activity of 6-phosphogluconic acid dehydrogenase was also found to decrease in both proliferative and hypertrophic zones following vitamin D
treatment (17); however, the activity of lactic dehydrogenase was not
significantly different in treated and untreated animals.

The relevance

of these findings to the calcification of cartilage matrix and degeneration
of cells cannot be postulated at this· time.
Recently, a study by Canas et al. (8) has demonstrated that one
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of the early effects of vitamin D on rachitic chicks is to stimulate bone
collagen synthesis by increasing the incorporation of

3

H-proline.

This

increased incorporation was reported as early as 12 hours after vitamin
D administration and before a rise in serum calcium was observed.

The

stimulatory action of the vitamin appeared to be specific for bone because collagen synthesis in the skin of these same animals was unaffected.

Nevertheless, it could not be determined whether the action of

the vitamin was on the DNA - m-RNA complex or on some enzyme( s)
directly responsible for the synthesis of collagen.

However. the results

do suggest that stimulation of bone collagen synthesis by vitamin D
would provide new matrix for the deposition of mineral made available
by the renewed absorption of gut calcium.
In conclusion, it can be said that the role of vitamin D in the
mineralization of bone matrix is still incompletely understood.

It is

known that vitamin D augments intestinal absorption of calcium and,
to a lesser degree, that of phosphate; this raises the serum levels of
calcium and phosphorus.

The observed increase in serum calcium is

largely the result of increased absorption.

However. the increased

level of serum phosphate following vitamin D administration probably
represents the summation of increased absorption and retention of
phosphate (mediated by high calcium levels with subsequent suppression

- 16 -

i

of plrathyroid hormone activity).

Beyond the systemic effects, vitamin

D a+ears to have some local action for even when the supplies of calcium' and phosphate are low, it is able, in the experimental animal, to
increase bone crystal formation.

At present, it can be stated only that

in the presence of dietary vitamin D calcification of the matrix of bone
occurs, while in vitamin D defiency this does not take place.

i

STATEMENT OF THE PROBLEM

The physiological action of vitamin D is directed to bone and
intestinal tissue.

In bone the vitamin acts by promoting accretion and

in the intestine its action is one of enhancing calcium absorption and
secondarily, that of phosphate.
It is well established that rickets results from a deficiency of

vitamin D with characteristic changes in the composition of bone such
as increased water and decreased ash content.

The development of

these changes in bone has been attributed to a decrease in the intestinal
absorption of calcium and secondarily, that of phosphate which leads to
a fall in the blood (Ca

++ )

=

(HP0 ) product (12).
4

What remains unclear is the role of vitamin D, at the biochemical
level, in the prevention and cure of rickets, particularly with respect
to the action of vitamin D on bone.

p
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Wasserman and Taylor (64) have shown that vitamin D induces the
synthesis of a calcium-binding protein in the intestinal mucosa of the
chick prior to an observable rise in serum calcium.

This has also

been reported in the rat (31) and dog ( 56).
Investigation into the nature of the interaction of vitamin D with
the mucosal cell that leads to the formation of a calcium-binding
protein suggests that vitamin D may be involved in some synthetic
process.

, This concept is derived from studies by Corradino et al. (11),

Zull et al. (66}. and Norman (40), in which it was demonstrated that
various inhibitors of protein synthesis partially or completely inhibit the
action of vitamin D.

Vitamin D, when administered to animals at

physiological levels, appears in high concentration as the vitamin or its
metabolites in the nuclei of intestinal mucosa! cells, which may also
reflect its molecular site of action (28, 29, 52).

Whether this nuclear

interaction represents a direct effect on the DNA - m-RNA complex or
an indirect alteration of the permeability characteristics of the nuclear
membrane is not known.

Work by Stohs et al. (53) and Hallick et al.

{23) has added support to the former hypothesis.

Whatever is the

mechanism, the product of the interaction has been proposed to be a
translocase or a transport enzyme (65).
Such a proposal for the action of vitamin D in bone has not as yet

- 18 been suggested.

The activities of various enzymes of the rachitic rat

epiphyseal or cartilage disc, following vitamin D administration, have
been investigated histochemically (2, 17).

However, the data obtained

do not appear to be consistent.
A recent study by Canas et al. ( 8) has demonstrated that one of
the early effects of vitamin D on rachitic chicks is to stimulate bone
collagen synthesis; this would provide new matrix for the deposition of

.mineral made

available by renewed absorption of gut calcium.

In

addition, the stimulatory action of the vitamin appeared to be specific
for bone, because collagen synthesis~ in the skin of these same animals
was unaffected.
The precise role of vitamin D in the mineralization of bone
matrix is still incompletely understood.

The biochemical events occur-

ring after the administration of the vitamin and prior to accretion have
not been investigated.

In contrast to the action of vitamin D in the

intestine, it is not known whether or not the action of the vitamin in
skeletal tissue is dire-cted upon the nuclear chromatin material or
nuclear membrane.

Since bone and the small intestine are target organs

for the vitamin, a reasonable hypothesis would be that the vitamin may
act in a fashion analogously to its action in the intestine and promote
the synthesis of a protein($) necessary for mineralization to occur.

........Jr.
- 19 It is the purpose of this dissertation to investigate this hypothesis by

stud:> ing the effect of vitamin D on the synthesis of ribonucleic acid in
rachi~ic

bone cells.

This information may possibly aid in establishing

the effect of the vitamin prior to accretion and its possible role in
curing or preventing rickets.

p
- 20 CHAPTER II
MATERIALS AND METHODS
EXPERIMENTAL DESIGN
There follows a brief description of the experimental approach
employed in studying the effect of vitamin D on the rate of synthesis of
ribonucleic acid in the bone cells of rachitic animals.
Male albino rats were maintained on a rachitogenic diet for four
weeks and the rachitic state was evidenced by reduced growth and an
increase in serum alkaline phosphatase activity.

The animals were then

divided into two groups one of which received vitamin D
control animals received the vehicle only.

3

whereas the

In those experiments em-

ploying actinomycin D to see whether or not the effect of the vitamin
could be blocked, a dose of 100 µg of the antibiotic was administered
intraperitoneally two hours prior to injection of either D

3

or the vehicle.

At various times after the administration of the vitamin or vehicle,
50 µg of

3

H-orotic acid were injected intraperitoneally two hours prior

to sacrifice.

Upon sacrifice, the femurs, tibiae and humeri were ex-

cised from each animal and placed in O. 9% sodium chloride solution.
The bones were then split longitudinally. scraped clean of bone marrow
using a scalpel, frozen and then pulverized into a fine powder before
homogenization.

The homogeriate was washed to remove acid-soluble
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and lipid components and the ribonucleic acid (RNA) was extracted from
the tissue residue with perchloric acid for 18 hours at 4

0

C.

In addition to RNA, the extracted fraction also contained protein.
The majority of the protein was removed by using the sodium dodecyl
sulfate - phenol method of Stohs et al. (53) except that the RNA was isolated in the last step by passing the aqueous layer through a Sephadex

.

G-25 column, instead of precipitating the RNA from the aqueous. layer
with ethanol and sodium acetate.

The RNA eluted from the column was

detected with a Uvicord II Absorptiometer set at a wavelength of 2 54 mµ.
The fraction eluted from the column containing RNA was flash evaporated
to dryness and the residue dissolved in distilled water.

Aliquots of this

sample were used to determine the amount of RNA present and for liquid
scintillation counting.
Absolute radioactivity determinations of

3

H-RNA were accomplished

with the use of a Beckman LS-250 liquid scintillation spectrometer.

The

specific activity of RNA was expressed as disintegrations per minute per
milligram of RNA (DPM/mg RNA).

A comparison of experimental and

control specific activities showed whether or not vitamin
the incorporation of

3

n 3 enhanced

H-orotic acid by increasing the rate of synthesis·

of RNA.
Positive identification of RNA was determined in the following

- 22 manner.

The· RNA remaining after flash evaporati?n• instead of being

dissolved in water. was hydrolyzed in KOH at 95° C for one hour.

The

nucleotides were removed from the hydrolyzate with the anion-exchange
resin Dowex 2X-8 and then eluted from the resin with HCl.

Separation

of the nucleotides was accomplished by placing them on a. column containing the cation-exchange resin Dowex 50W -X4 and eluting first with
HCl and then water.

A Uvicord Il Ultraviolet Absorptiometer was

utilized for detection of the mononucleotides as they were eluted from'
the column.

The fraction containing uridine monophosphate was flash

evaporated and the residue dissolved.in water.
Thin-layer chromatography and the Cary Model 15 recording
spectrophotometer were employed for the positive identification of
uridine monophosphate.

Development of cellulose thin-layer sheets was

carried out at room temperature by ascending chromatography.

Along

with a standard solution of uridine monophosphate, solutions of the
monophosphates adenosine. guanosine and cytidine were also used for
identification of components other than uridine monophosphate in the
sample.

The components were located on the thin-layer chromatogram

with ultraviolet light.

Uridine monophosphate was removed from the

chromatogram and a spectral analysis was determined using the Cary
Model 15 spectrophotometer.

p

-------------------------------------------------------------------------.
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A. Animal Maintenance Prior to Experiments
Three week old male albino rats, 50-60 grams in weight,
(Holtzman Company, Madison. Wisconsin) were housed in suspended
cages in an air-conditioned room from which sunlight was excluded.
The animals were divided into two groups.

One group was provided a

normal diet (Rockland Laboratory Animal Diet) and tap water.

The rats

in the second group were placed on a rachitogenic diet (General Biochemicals, Chagrin Falls, Ohio) containing a high calcium to phosphorus
ratio (Ca/P = 5. 85) and no vitamin D; in addition, these animals were
given only distilled water to drink.

At the end of four weeks those

animals on normal rat chow weighed approximately 200 g. whereas
animals on the test diet exhibited a weight range of from 70 to 90 g.

B. Determination of Serum Alkaline Phosphatase Activity
In order to establish whether or not the animals were rachitic,
two parameters were used.

In addition to reduced growth, the level

of serum alkaline phosphatase activity was determined; an increase in
alkaline phosphatase activity would be indicative of the rachitic state.
p.,..Nitrophenylphosphate was used as the substrate for the determination of phosphatase activity.

The substrate was dissolved in an

alkaline buffer (pH - 9. 4) and allowed to react with the serum phospha-
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tase for 30 minutes at room temperature.
by the addition of NaOH.

The reaction was terminated

The p-nitrophenol liberated by the phosphatase

exhibits a yellow color in alkaline solution and the phosphatase activity
is diredly proportional to the amount of p-nitrophenol liberated per unit
time.

Preparation of Solutions
1. p-Nitrophenol (5 x 10-

3

M):

Dissolve 696 mg of p-nitrophenol

(Sigma) in O. 02 N NaOH and dilute to one liter with the base.
2. Working Standard (1. 38 x 10- 4 µm/µl):

To 10 µl of 5 x 10- 3

•

add 350 µl of O. .02 -N NaOH.
-M p-nitrophenol,
.
.

3. Buffer Solution (pH - 9. 4):

Take 50 ml of O. 2 M Na2 co 3 and

to it add 200 ml of O. 2 M NaHC0 .
3
4. Alkaline Buffer - Substrate Solution:

Dissolve 20 mg of p-

nitrophenylphosphate (Sigma) in 5. O ml of doubly distilled water ..
To this add 175 ml of the alkaline buffer solution (pH - 9. 4).
Pipette 100 µl aliquots of this solution into micro test tubes
(Beckman) and store at - 10° C until ready for use.

The experimental approach used in determining serum alkaline
phosphatase began with the collection of four hundred microliters of
blood from rats which had been maintained for four weeks on a

,.;:=----------------------------------.. . .
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parti!\ular dietary regimen.
for t ese experiments.
the r t.

Three rats from ea<;!h group were chosen

Blood samples were obtained from the tail of

The rat was placed in a restraining cage and the tail was

\

severed· approximately three-quarters of an inch from the tip.
was aided by "milking" the tail.

Bleeding

Blood was collected in plastic micro-

tubes and these were allowed to stand at room temperature for ten
minutes.

Centrifugation was performed in a Beckman/Spinco Microfuge

for one' minute.

I

The serum was set aside until ready for use.

Micro test tubes containing 100 µl of the alkaline buffered substrate
were removed from the freezer and left at room temperature for about
one hour.

To one of these tubes was added 5 µl of distilled water.

a second tube was pipetted 5 µl of the working standard solution.
third tube was pipetted 5 µl of serum.
30 second intervals.

Into

Into a

The 5 µl additions were made at

All samples were left at room temperature for 30

minutes and the reaction in each tube was stopped by the addition of 200
µl of O. 02 N NaOH.

The Spectro-Colorimeter was set at zero absorb-

ance against water and the optical density of the resulting solutions was
determined at 410 mµ.
A :unit of alkaline phosphatase activity was defined in these experiments as that amount of enzyme that will liberate 1. O µm of p-nitrophenol in one hour at pH - ·9. 4 and 25° C.

For comparison of sera

- 26 normal and rachitic animals the activity was expressed as units of
enzyme activity per ml of serum.
A standard curve for determining alkaline phosphatase activity was
prepared by taking various aliquots of the working standard and measuring the optical density of the resulting solution at 410 mµ in the
Beckman/Spinco 151 Spectro-Colorimeter.
curve appear in Table I.

The data for this standard

A linear relationship between the optical

density readings at 410 mµ and the concentration of p-nitrophenol is
shown in Fig. 1.

.

C. Experiments with and without Actinomycin D
Preparation of Solutions
1. Vitamin

o3:

Dissolve 5 mg of crystalline vitamin

o3

(Mann

Laboratories, New York) in 0. 5 ml of 95% ethanol and dilute
to 10 ml with propylene glycol (1, 2-propanediol).
grams of vitamin

o3

Five milli-

are equivalent to 200, 000 International

Units (I. U. ); therefore, one milliliter of this solution would contain 20, 000 I. U.
2. Control Vehicle for Vitamin

o 3:

O. 5 ml of 95% ethanol was

placed in a volumetric flask and diluted to 10 ml with
propylene glycol.

PF
.

.

.
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!!\"

f.

["'

~:·

~,·.

TABLE I

Standard Curve Data' for Determination of Alkaline Phosphatase Activity

µm p-Nitrophenol
x 10- 3

O. D. 410

*

No. of Sam2les

0.690

4

0.023 : 0.005

1.38

4

0.044: 0.015

2.76

4

0.086: 0.017

4

0.175:: 0.011

8.28

4

0.260

+ 0.022
-

11.04

4

0.341

+ 0.005

13.8

4

0.415 +
- 0.028

5.52

* mean

+- standard deviation

•

-
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FIGURE 1
Standard Curve for Deterrriinatfon of Serum Alkaline Phosphatase Activity
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3. Orotic Acid-5-T ( H-orotic acid):

3

H-orotic acid (specific

activity = 14-16 Ci/mM) was obtained from Amersham/Searle,
Chicago, and dissolved in physiological saline (0, 9%) such
that 50 µc were equivalent to O. 25 ml.
3
4. Uridine-5-T ( H-uridine):

3

H-uridine (specific activity =

22. 7 Ci/mM) was obtained from Amersham/Searle and dissolved in physiological saline (0. 9%) such that 50 µc were
equivalent to 0. 2 5 ml.
5. Actinomycin D:

Dissolve 1000 µg of actinomycin D (Cal-

biochem) in 5. O ml of O. 9%

•

salin~:95%

ethanol (9:1).

The

control vehicle for actinomycin D was the solution of
' saline :ethanol (9: 1).

Experiments without Actinomycin D:

Rachitic rats ( 70-90 g), main-

tained on the rachitogenic diet for four
before the start of each experiment.
arranged so_ that all

t~e

week~.

were fasted 13-15 hour_s

The fasting of these animals was

experiments began at 7:00 A. M.

On the day of

the experiment the animals were divided into two groups, each group
comprising 4 to 5 animals.
(0. 25 ml) of vitamin

o3

One group of animals received 5000 I. U.

intraperitoneally whereas the control animals

received only the vehicle.

At various intervals (i.e., 1, 4, 7, 10 or 13

- 30 hour ) after administration of the vitamin or vehicle, 50 µ.c of
oroti
tion

3

H-

acid were injected intraperitoneally; two hours after administra~f

the isotope, the animals were sacrificed. Both femurs. tibiae
I
and humeri were excised from each animal, scraped clean of extraneous

tissue and placed in ice-cold physiological saline.

Each bone was then

split longitudinally, scraped clean of bone marrow using a scalpel and
then frozen.

Experiments with Actinomycin D:

Actinomycin D was employed to see

whether or not the enhanced incorpor.ation of tritiated orotic acid into
RNA by the vitamin was blocked.

Animal preparation prior to the ex-

periment was the same as described above.

However, on the day of

the experiment the animals were divided into four groups of four animals
each, such that a dose of 100 µ.g of actinomycin D or its vehicle was
injected intraperitoneally two hours prior to the administration of either
vitamin
A. M.

o3

(5000 I. U.) or its vehicle.

All experiments began at 5:00

Only one time interval (i.e .• 9 hours) was used and either

orotic acid ( 50 µ.c) or

3

3

:a-

H-uridine ( 50 µ.c) was injected intraperitoneally

two hours prior to sacrifice; this would mean that the isotope was administered on the seventh hour and the animals were sacrificed on the
ninth hour.

The removal and cleaning of the bone was the same as

described above.
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n.

aration of Tissue Residue for Extraction of RNA (ribonucleic acid):
1\ Pulverization of Bone:

Before whole bones could be homogenized

they had to be reduced to a fine powder.

This was accomplished by

I
I

using a· stainless steel tissue pulverizer (Vollrath Company. Sheboygan.
Wisconsin) packed with dry ice.

Once the metal was cold whole bone

samples were removed from the freezer and placed in the cylindrical
portion of this apparatus.

By repeated hammering a fine bone powder

was oJtained.
I

2. Homogenization and Preparation of Tissue Residue:
employed was essentially that of Pa:r,:k et al. (44).

The technique

Powdered bone was

homogenized with· 20 ml of a mixture of ice cold 95% ethanol and 2%
potassium acetate (2:1); the glass tissue homogenizer was placed in a
beaker of ice and several passes were made before complete homogenization was accomplished.

The homogenate was then

cen~rifuged

at

4000 r.p.m. in the Model PR-2 International Portable Refrigerated
Centrifuge at

o° C for 15 minutes.

After discarding the supernatant.

the pellet was suspended in 15 ml of O. 5 N perchloric acid.
minutes for decalcification at
4000 r._p. m. for 5 minutes at

After _30

o° C. the suspension was centrifuged at
o° C.

Acid solubfo and lipid components

were extracted by twice washing the residue with 15 ml of cold

o. 1

N

perchloric acid in ethanol (95%). then with 15 ml of ethanol:ether (3:1)
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first cold. then twice at 50° C.

Finally, the residue was washed twice

in 15 ml of cold O. 5 N perchloric acid to remove the remaining calcium
rnatri~
I

of bone.

E. Extraction of RNA
Extraction of RNA from the bone tissue residue was accomplished
by using the combined methods of Ogur et al. (42) and Stohs et al. (53)
with slfght modifications.
!

Ogur et al. (42) Method:

The RNA was extracted from the de-

calcified bone tiss_ue residue free from .acid soluble and lipid components
with 1. 0 N perchloric acid for 18 hours at

4°

C.

The supernatant ob-

tained after centrifugation was neutralized with 10 N KOH at approximately

4°

C and then placed in the cold at

o°

C for 30 minutes; the KClO

precipitate was then removed by centrifugation at

Stohs et al. (53) Method:

o°

4

C.

This method was employed to remove

the protein that was extracted along with the RNA.
KClO

4

After removal of

in the above step, the supernatant was flas_h evaporated (Model

PTFE-IGN Evaporator, Buchler Instruments) to dryness at 35

0

C.

To

the residue was added 5. O ml of O. 01 M acetate buffer (pH - 5. 0)
followed by centrifugation at an International Clinical Centrifuge to re-

33 move insoluble material.

Sodium dodecyl sulfate, O. 5 ml of a 10%

solution, was added to the supernatant and the suspension was stoppered
and placed in a shaker water bath (Elmac Engineering, Chicago, Illinois)
at 65

0

C.

In addition, a tube containing 5. O ml of 88% phenol was

simultaneously placed in the bath.

After 5 minutes the hot phenol was

added to the suspension and this mixture was shaken for another 5
minutes at 65° C.

The emulsion was removed from the bath and

rapidly cooled by placing it in a beaker of ice cold water.

The

emulsion was then broken by centrifugation (Servan SS-1) at 30, 000 x g
for 10 minutes.

The aqueous layer was removed by pipetting and the

phenol phase, pelleted material and interphase were discarded.

The

extraction procedure was repeated one more time with addition of
sodium dodecyl sulfate and hot phenol.

The aqueous phase remaining

after the second extraction was flash evaporated to dryness at 35° C.

Removal of Phenol with Sephadex G-25 (21):

To separate the

from any phenol contamination Sephadex G-25 was used.

RNA

Fifty grams of

Sephadex G-2 5 Coarse (Pharmacia Fine Chemicals) were placed in a
beaker and washed several times with distilled water and the small
particles were removed by decantation.
beads were left at room

t~mperature

After washing, the Sephadex

for one hour in distilled water.

The swollen gel particles while being gently stirred were then poured

into
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l

column (2. 5 x 45 cm; Pharmacia).

place~

A sample applicator was

on top of the column in direct contact with the Sephadex beads;

the applicator is simply a cylindrical piece of plastic open at the top
but whose bottom contains nets of nylon.

A sample to be applied is

first dissolved in a solvent (in this case 20% sucrose) whose density is
greater than that of the eluent (distilled water) and then applied through
a hole in the top of the column directly onto the nylon netting.

~o
I

.;·_

'.

'·

the residue remaining after flash evaporation at 35° C, as

described in the last step under the method of Stohs et al. (53). was
added 4. O ml of 20% sucrose; the insoluble ~aterial was removed by
centrifugation (clinical centrifuge).
3

The sucrose supernatant containing

H-RNA was drawn up with a 5. O ml syringe (an 18 gauge, 6 inch

needle was attached to this syringe) and with the aid of a sample applicator was applied to the column.
rate of flow was 3. O ml/min.
set at a wavelength

o~

Distilled water was the eluent and the

A Uvicord II Ultraviolet Absorptiometer

254 mµ was used for detection of RNA.

The

RNA was first detected with the Uvicord recorder after 75-80 ml of
eluent had passed through the column; the next 30-40 ml of eluent were
collecte·d in a single flask.

Collection of this single fraction was termi-

nated when the recorder read essentially 100% transmission.

This

fraction containing RNA was then flash evaporated to dryness at 35° C.
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\

esidue was dissolved in 2. O ml of distilled water and aliquots of

this

r

ample were used to determine the amount of RNA present and for

liqui ' scintillation counting.

In those experiments designed to show that

I

3H-orotic acid was indeed being incorporated into RNA the residue re maining after flash evaporation was processed in a manner to be
described later.
The amount of RNA was determined by using a standard yeast
~-·-.

RNA (Sigma) sample and the Beckman DU spectrophotometer at a wave1

.

I

length of 260 mµ.

The Cary Model 1.5 spectrophotometer was also

employed for a spectral analysis of .each sample.

F, Liquid Scintillation Counting
. Toluene Counting Solution:

5. 0 g of PPO (2. 5-diphenyloxazole)

, were dissolved in one liter of toluene.

To every 100 ml of

this solution was added 20 ml of Beckman solubilizing reagent (Bio-Solv-BBS-3); this solution was the toluene cocktail
used for counting purposes.

A 1.. O ml aliquot of the sample was placed in a liquid scintillation
counting vial and to this was added 1.0 ml of the toluene counting
solution.

The samples were counted with the LS-250 Liquid Scintillation

Spectrometer (Beckman In'strwitents).

The specific activity of RNA was

- 36 as disintegrations per minute per milligram of RNA (DPM/
A comparison of experimental and control specific activities

mg
reve

ed whether or not vitamin
\

uridine or

3

o3

enhanced the incorporation of

3

H-

\

H-orotic acid by increasing the rate of synthesis of RNA.

G. Hydrolysis of RNA
In order to show that
porated into

3

3

H-orotic acid was indeed being incor-

H - RNA, the final RNA residue remaining after flash evap-

1

oration was not dissolved in 2. 0 ml of distilled water but instead was
processed in a manner to be descriped in this and subsequent steps.
To the dry RNA sample was added 10 ml of O. 05 M KOH and the
RNA was hydrolyzed to the mononucleotides by heating at 9 5° C in a
water bath for 60 minutes.

The hydrolyzate was cooled to 4

then neutralized with 5 N HClO .
4
minutes the KClO

4

0

After precipitation at O

was removed by centrifugation.

0

C and

C for 30

The supernatant was

retained for purification of the ribonucleotides.

H. Ribonucleotide Purification with Dowex-2

Preparation of Anion-Exchange Resin:

One and a half grams of

Dowex-2-XS (200-400 mesh; Bio-Rad Laboratories) were alternately
treated with 30 ml of 1. N. NaOH and 30 ml of 1 N HCl.

The resin was
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then washed five times with 1 N HCl (30 ml) to remove the very fine
,.,_,

particles.

Finally. the washing procedure was performed twice with

f

~;~

r·

doubly distilled water and the resin was kept wet until needed.

Adsorption and Elution of the 2', 3' - Ribonucleotides:

To the neu-

tralized solution of mononucleotides (i.e., supernatant remaining after
KClO
of

4

precipitation as described above) was now added an equal volume

o. 05 M Tris-HCl buffer (tris hydroxymethyl aminomethane hydro-

chloride) pH - 7. 8.

To this solution was added the washed Dowex-2-X8
\

and the mixture was left at room temperature with- occasional stirring
•

for 30 minutes.

_After centrifugation (clinical centrifuge) the supernatant

was discarded and the resin was transferred to an ultra-fine sintered
glass filter (50 ml) with O. 025 M Tris-HCl buffer, pH·7. 8.

The buffer

was removed by suction and discarded and to the resin was added 1. O
ml of 1. O N HCl.

After 30 minutes, . and with occasional stirring, the

mixture was filtered by suction.

The filtrate contained the ribonucleo-

tides in 1. O N HCl.

I. Separation of 2', 3' -Ribonucleotides (32)

The separation of the 2', 3' -ribonucleotides on a cation exchange
resin by elution first :with HCl and then water takes advantage of the
fact that below pH - 2. O the g1;1anosine.. adenosine and cytidine mono-
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phosphates (GMP, AMP and CMP) have charged amino groups and are
exchanged on the column whereas uridine monophosphate (UMP) passes
through.

Since the pK of the amino group of G MP of 3. 2 is approxi-

mately. 1. 3 pH units below CMP and AMP, it is eluted immediately
after water is passed through the column.

The CMP and AMP with

similar pK' s were eluted together.

Preparation of Cation-Exchanger Dowex 50W-X4:

Fifty grams of

Dowex 50W-X4 (200-400 mesh; Bio-Rad Laboratories) were washed five
times with doubly distilled water and then twice with O. O5 N HCl.

The

•

resin was then mixed with 0. 05 N HCl and with gentle stirring was
poured into a column (0. 9 x to cm).

The flow rate was O. 76 ml/min

and detection of the nucleotides as they were eluted from the column
was again performed with the Uvicord II Ultraviolet Absorptiometer at a
wavelength of 254 m1-1.
The sample (nucleotides in 1. O ml of 1. O N HCl) was applied to
the column and allowed to drain to the top of the resin.

The sides of

the column were then washed down with 1. O ml of O. 05 N HCl, which
was allowed to drain to the top of the resin.

Three milliliters of O. O5

N HCl were then added to the top of the resin and the column was
attached to a reservoir containing O. 05 N HCl.

UMP was detected

after 4. O ml of HCl effluent were collected; the UMP was then
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collected as one fraction (approximately 3. O ml).

The HCl was now

allowed to drain to the top of the resin and 3. O ml of water were
added.

The column was attached to a reservoir containing distilled

water and GMP was detected after 5. 0 ml of water effluent were
collected; GMP was collected over the next 3 - 4 ml.

The next 25 - 30

ml of water passed through the column eluted CMP and AMP together.
The various fractions (i.e .• UMP, GMP or AMP-CMP) were then
flash evaporated to dryness at 32

0

C.

J. Thin-Layer Chromatography
To identify the UMP fraction thin-layer chromatography was employed in conjunction with the Cary Model .15 recording spectrophotometer.
The solvent system used for thin-layer chromatography (9) was

t

:

L

isopropyl alcohol-concentrated HCl-water

(65:16~

7:18. 3).

Development

of the cellulose thin-layer sheet containing fluorescent indicator was
carried out at room temperature by ascending chromatography with
chromatographic tanks purchased from the Kensington Scientific
Corporation, Oakland, California.

The various mononucleotide fractions

were dissolved in 0. 3 ml of 1. O N HCl and 20 µl aliquots were applied
to the cellulose sheets.

Standard solutions of the 2' and 3' mono-
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phosphate (mixed isomers; Schwarz Bioresearch, Inc., New York) of
GMP. AMP, CMP and UMP were employed for identification of the
components in the

3

H-RNA hydrolysate.

The concentration of the stan-

dard solutions was approximately 2. 5 µg/µl and 10 µl aliquots were
applied to the cellulose sheets.
Development of the chromatogram took one hour; the sheet was
then air dried and the components were identified by ultraviolet light
(UVS-11 Mineralight; Ultraviolet Products, San Gabriel, California).
The standard UMP spot was cut out ,.and the cellulose scraped from the
sheet into a test tube.

Two milliliters of 0. 1 N HCl were then added

and the tube was mixed and left at room temperature for 30 minutes.
After centrifugation the supernatant containing UMP was retained for
spectral

analysis~

The UMP from the RNA hydrolysate was cut out and

processed in the same manner as just described.

A blank was prepared

by cutting out a spot on the cellulose sheet of approximately equal area
and with the same Rf _value as the UMP spots; it was treated in the
same manner as the UMP samples.

p.
[.;.
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CHAPTER III
EXPERIMENTAL RESULTS
'Experiment 1:

Determination of Serum Alkaline Phosphatase Activity

in Normal and Rachitic Rats.
As described in the section on Materials and Methods, the level
of serum alkaline phosphatase was used as a parameter to determine
whethir or not rats were rachitic.

Prior to all experiments, three

I

rats were chosen at random for these determinations from a population
•

of 30 animals maintained on the rachifogenic diet for approximately four
weeks.

Serum samples for phosphatase assay were also obtained from

control animals fed normal rat chow during the same four week period.
The values in Table II represent the total number of determinations
that were made.

In all cases the serum of rachitic rats exhibited a

higher level of phosphatase activity and this difference is significant at
P<0.01.

Experiment 2:

Effect of Vitamin

o3

on the Incorporation of

3

.

..

H-Orotic

Acid into RNA of Rachitic Rat Bone.
Rachi tic rats were fasted 15 hours prior to the start of the experiment which began at 7:00. A.~-

On the day of the experiment five

·animals received 5000 I. U. of vitamin

o 3 intraperitoneally and five

- 42 TABLE II

SERUM ALKALINE PHOSPHATASE ACTIVITY
OF NORMAL AND RACfilTIC RATS

(units /ml serum}

*2.20
*Mean

Normal

Rachi tic

1.94

3.92

2.80

3.56

2.20

3·."70

1. 80

3.58

2.20

3.68

2.56

2.96

2.12

3.02

2.20

3. 82

1.92

3.86

2.74

3.44

2.34

3.80

1.68

3.86

"!:

0. 34

+- standard deviation.

cant at P

< O. 01.

*3.60

+
.
- 0.30

The difference between means -is signifi-
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received the vehicle only.

Two hours prior to sacrifice at 3, 6, 9 or

12 hours all animals received 50 µc of

3

H-orotic acid.

Upon sacrifice,

the femurs, tibiae and humeri were removed from each animal, placed
in O. 9% saline and then split open and cleaned as described under
Materials and Methods.
pooled.

The bones of five animals within a group were

The bones were then pulverized and homogenized and the RNA

was extracted.

The extracted RNA was separated from phenol on a

Sephadex G-25 column.
in Figure 2.

The results of this separation are illustrated

The RNA fraction was eluted from the ~olumn, flash-

evaporated to dryness and then dissolved in distilled water.
spectrum of the RNA so isolated is shown in Figure 3.

A

Aliquots of

RNA dissolved in distilled water were used to determine the concentration and the absolute radioactivity of the

3

H- RNA.

The concentration of

RNA was determined by using a standard yeast RNA (Sigma Chemical
Company) sample and the Beckman DU spectrophotometer set at a
wavelength of 260 mµ;

The total amount of RNA isolated in this and

subsequent experiments exhibited a concentration range of from 20-0 µg
to 250 µg.

and the specific activity is expressed as disintegrations per

minute per milligram of RNA (DPM/mg RNA).

From the data given

in Table III. it is seen that the vitamin enhances the incorporation of
3

H-orotic acid into RNA.

~hen. adm~nistered

1, 4 and 7 hours before
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FIGURE 2
Separation of RNA from Phenol on Sephadex G-25 Column.

(I) RNA Ob-

tained from Bone of Rachitic Rats, (TI) Unidentified Fraction, (III) Phenol.
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FIGURE 3
(I) Spectrum of RNA Isolated from Bone of Rachitic Rats,
.
.
(II) Spectrum of Yeast RNA (Sigma Chemical Company).

.
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TABLE III

1INFLUENCE OF 5000 I. U. OF VITAMIN
OF

3

n 3 ON THE INCORPORATION

H-OROTIC ACID INTO RNA OF RACHITIC RAT BONE*

Specific Activity of

3

H-RNA
(dpm/mg RNA) **

I

· Time /
(hr)

Control

-

1840 -

2480 -

74

3010 -

2920 +-

88

3960 - 119

4100 +- 123

3790 - 114

1660

6
9

+

12

n3

+

50"

3

*Vitamin

+

Vitamin D3

+

55
90

+
+

deficient rats maintained on a diet with a high Ca:P

ratio were sacrificed 3, 6, 9 and 12 hours after having received
5000 I.U. of vitamin
received 50 µc of

3

n 3 or vehicle intraperitoneally.

All · rats

H-orotic acid 2 hours before sacrifice.

The

specific activity of the labeled RNA at each time interval was
determined on pooled samples of bone obtained from 4 or 5 animals.
**Specific activity +
- 3% counting error.
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the tracer.

The specific activity of the labeled RNA increases as the

exposure time of the animals to the vitamin is increased.
appears that the incorporation of
I

fluenced by vitamin D

Experiment 3 :

3

3

However, it

H-orotic acid into RNA is not in-

when administered ten hours before the tracer.

Use of the Ion - Exchange Resins Dowex 2 and Dowex 50

to Isolate and Separate the 2', 3' -Ribonucleotides of RNA Obtained from
the Bod e of Rachitic Rats.
This experiment was
aci~

.

performe~

to demonstrate . that

3

H-orotic

was
being
incorpor.ated into . RNA..
.
..
.

.·

To a dry sample of extracted RNA, free from any contamination
with phenol, was added 0. 05 M KOH.

The RNA was hydrolyzed to

mononucleotides by heating it at 95° C for 60 minutes.

The pH of the

resultant solution was adjusted to 7. 8 and the 2', 3' -ribonucleotides were
adsorbed on Dowex 2 anion-exchange resin and then eluted from this
resin with 1. 0 N HCL
Separation of ribonucleotides was accompllshed with the use of a ·
column containing the

c~tion-exchange

resin Dowex 50.

UMP was eluted

with 0. 05 N HCl; GMP, AMP together with CMP were eluted with
distilled water.

Figure 4 shows the pattern of elution of the nucleotides

as they were detected with. the Uv icord II Absorptiometer set at a wavelength of 2 54 mp..

The spectra of the UMP and GMP separated from
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FIGURE 4
Separation of 2'. 3' -Ribonucleotides from the Alkaline Hydrolysis of RNA
Obtained from Bone of Rachitic Rats.

(I) Uridine Monophosphate, (II)

Guanosine Monophosphate. (III) and (IV) are Mixed Isomers of the Monophosphates of Cytidine and Adenosine.

(I) Was Eluted with 0. 05 N HCl,

(II), (III) and (IV) \Vere Eluted with Doubly Distilled Water.
of Nucleotides was performed on a Dowex 50W -X4 Column.

Separation

- 49 the mononucleotides appear in Figures 5 and 6.

They were determined

on aliquots taken from the fractions represented as Peak I and Peak II
in Figure 4.

Experiment 4:

Identification by Thin-Layer Chromatography of 2 ', 3' -

Ribonucleotides Isolated from the Alkaline Hydrolysis of RNA Obtained
from Bone of Rachitic Rats.
The experiment was undertaken to obtain evidence, in addition to
3

that already obtained, that

H-orotic. acid was indeed qeing incorporated

into RNA.
The various mononucleotide fractions of (I) UMP, (II) GMP and
(III - IV) AMP together with CMP were separated from the alkaline
hydrolysate of RNA obtained from bone as described in Experiment 3
and illustrated in Figure 4.

After elution from a column of Dow ex 50,

these fractions were flash-evaporated to dryness at 32° C and the dry
material in each cas_e ·was d~ssolved .in O. 3_ ml of 1._0 N ~CL

Aliquot~

of the different nucleotides were applied to a thin-layer cellulose sheet·
with fluorescent indicator and development of the chromatogram was
accomplished in one hour with a solv.ent system composed of isopropyl
alcohol-concentrated HCl - water (65:16. 7:18. 3).

.

.

Following ascending

chromatography, the nucleotides were identified by ultraviolet light.
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FIGURE 5
(I) Spectrum of UMP Separated from Mononucleotides Obtained

from the Alkaline Hydrolysis of RNA Isolated from Bone of
Rachitic Rats, (II) Spectrum of Standard UMP (Schwarz BioResearch)
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FIGURE 6
(I) Spectrum of Standard GMP (Schwarz BioResearch)

(II) Spectrum of GMP Separated from the Alkaline Hydrolysis
of RNA Isolated from Bone of Rachi tic Rats.
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The chromatogram illustrated in Figure 7 shows that the spots
represented by V and VI are UMP and GMP respectively.

Additional

evidence for the isolation of UMP was obtained by cutting out the spots
represented by I (standard UMP) and V (UMP obtained from RNA of
bone) in Figure 7 and eluting them from the cellulose sheet with O. 1 N
HCL

The spectra of the nucleotides are illustrated in Figure 8 .

...

Although it is not described in this experiment, res.olution of
spot VII in Figure 7 into AMP and CMP was accomplished by using an
additional solvent system containing- saturated ammonium sulfate - O. 1
M sodium phosphate buffer (pH 6. O) - isopropyl alcohol (79:19:2).

Experiments 5 and 6:

Effect of Vitamin

o3

on the Incorporation of

3

H-

Orotic Acid into RNA of Rachitic Rat Bone.
The following two experiments were performed to delineate further
the time interval at which a maximum response to vitamin
be observed.

o3

could

The experiments were conducted in the same fashion as

in Experiment.2 except that the. rats were sacrificed at 6, 9 •. 12 and 15
hours after having received vitamin

o3

or the vehicle.

that any increase in the rate of incorporation of
RNA produced by vitamin

o3

is questionable.

Table V appear to indicate that vitamin

o3

3

Table IV shows

H-orotic acid into

However. the results in

enhanced the incorporation
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· FIGURE 7: Identification by Thin-Layer Chromatography of 2'. 3' -Ribonucleqtides Isolated from an
Alkaline Hydrolysate of 3H-RNA Obtained from Bone of Rachitic Rats. Standards of UMP (I). CMP
(II). AMP (III) and GMP (IV) were obtained from Schwarz BioResearch. The Nucleotides (V) UMP,
(VI) GMP, and (VII) AMP-CMP were initially separated from the alkaline hydrolysate using a Dowex
50 column as illustrated in Figure 4. Development of the chromatogram takes one hour using an
ascending solvent system composed of isopropyl alcohol-concentrated HCl-water (65 :16 . 7:18. 3) .
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FIGURE 8: (I} Spectrum of Standard UMP (Schwarz BioResearch), (TI)
Spectrum of UMP Isolated from an Alkaline Hydrolysate of 3H-RNA Obtained from Bone of Rachitic Rats . (I) and (TI) were chromatographed on a
cellulose thin-layer sheet using an ascending solvent system of isopropyl
alcohol-concentrated HCl-water (65:16. 7:18. 3) and then eluted from the
sheet with O. 1 N HCl.
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TABLE IV
INFLUENCE OF 5000 I. U. OF VITAMIN
I

OF

3

o ON THE INCORPORATION
3

H-0ROTIC ACID INTO RNA OF RACHITIC RAT BONE*

Specific Activity of

3

H-RNA
(dpm/mg RNA) **

Time
(hr)

Control

6

+
2020 - 61

9

2640

12

2330

15

2270

*vitamin

o3

+ •
79
+

70

+

- 68

Vitamin 03
+
2370 - 71
2790
2500

+
+

84
75

+
2300 - 69

deficient rats maintained on a diet with a high Ca:P

ratio were sacrificed 6, 9. 12 and 15 hours after having received
5000 I. U. of vitamin

received 50 µc of

o3

or vehicle intraperitoneally.

All rats

3
_H-orotic acid 2 hours before sacrifice.

The

specific activity of the labeled RNA at each time ·interval was determined on pooled samples of bone obtained from 4 or 5 animals.
**Specific
.
. .
+- 3~o counting error.
activity
7
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TABLE V
INFLUENCE OF 5000 I. U. OF VITAMIN
OF

3

n 3 ON '.J'HE INCORPORATION

H-OROTIC ACID INTO RNA OF RACffiTIC RAT BONE*
3

Specific Activity of

H-RNA
{dpm/mg RNA) **

Time
Control

. {hr)

+

-

Vitamin

6

f 340

9

1600 + 48

+

1910 - 57

~o.

-

n3

+

~

2370 - 71

12

i760

+ 53
-

2280 - 68

+

15

1700 +
- 51

2940 - 88

+

*Vitamin n deficient rats maintained on a diet with a high Ca:P
3
ratio were sacrificed 6, 9, 12 and 15 hours after having received
5000 I. U. of vitamin

received· 50 · µc of

3

n 3 or vehicle intraperitoneally.

~ -orotic ·acid

2

ho~s

All rats

before sacrifice.

The

specific activity of the labeled RNA at each time interval was
determined on pooled samples of bone obtained from 4 or 5 animals.
**Specific activity +
- 3% counting error.

- 57
of

3

-orotic acid and that the specific activity increased with time.
The results of Experiments 2. 5 and 6 are summarized in Table

VI and Figure 9.

These data indicate that the highest specific activity

I

is observed nine hours after the administration of vitamin

n with a
3

decrease being observed by the 12th hour.

Experiments 7 and 8:

Effect of Vitamin

n 3 on the Incorporation of 3 H-

Orotid Acid into RNA of Rachitic Rat Bone Nine Hours after the
Administration of the Vitamin.
In order to . discern whether or not the response produ~ed by
vitamin

n observed in Figure 9 was indeed significant at 9 hours.
3

two additional experiments were performed at this time interval only.
On the day of the experiment the rachitic animals were divided
into two groups of five animals each.
of vitamin

Five animals received 5000 I. U.

n 3 and five received the vehicle only.

all animals received · 50 µc of

3

H-orotic

. . . . . -!

were sacrificed.

ac~d

Seven hours later

and two hours

1~~71:

they

Upon sacrifice. the. femurs. tibiae and humeri were

removed from each animal. placed in ice-cold O. 9% saline and then
split open and cleaned.

The bones were then pulverized and homog-

enized and the RNA was extracted.
The results of Experiments 7 and 8 and those of Nos. 2. 5 and

- 58 -

TABLE VI
INFtUENCE OF 5000 I. U. OF VITAMIN D
·'

OF

3

3

ON THE INCORPORATION

H-OROTIC ACID INTO RNA OF RACHiTIC RAT BONE*

Specific Activity of

3

(dpm/mg RNA)

H-RNA

**

Time
No. of Experiments

(hr)

Vitamin

Control

o3

3

i

+
i660 - 49

1840 ~ 45

6

3

+
1947 - 53

2430 ~ 73

9

3

+
2387 - 72

3040 : 91

12

3

+
2730 - 82

+
2856 - 86

15

2

1985 ~ 60

2620 + 79

*vitamin

o3

deficient rats maintained on a diet with a high Ca:P

ratio were sacrificed 3, 6, 9, 12 and 15 hours after having received

5000 I. U. of

vitam~n

o3

or vehicle intraperitoneally.

received 50 · µc of 3 ~-orotic

~~id: 2

hours befo.re-

All rats

~~c;ifice~

For

each - experiment at each time interval the specific activity of labeled
RNA. was determined on pooled samples of bone obtained from 4 or
5 animals.

** The values represent the mean +- 3% counting error.
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FIGURE 9
Vitamin D

3

Stimulated Increase in Rate of RNA Synthesis in Bone of

5000 I. U. of Vitamin n or Vehicle were administered
3
3
intraperitoneally followe~ by s.o µc of H-orotic acid two hours prior to
Rach.itic Rats.

sacrifice at 3, 6, 9, 12 or 15 hours. (•·- - - - • - - - •) Vitamin
0

- - - o ) Controls.

- 60 6 are summarized in Table VII.

In all cases the data show an increase

in the rate of RNA synthesis, as evidenced by a higher specific activity,
9 hours after the administration of vitamin
control and

Experim~nts

n 3.

The difference between

n 3 - treated animals is. significant at P

9 and 10:

lated Incorporation of

=

0. 05.

Effect of Actinomycin D on Vitamin D
3

3

Stimu -

H-Orotic Acid into RNA of Rachitic Rat Bone.

Once it was established that the stimulatory action of the vitamin
was significant at 9 hours, experirnents with actinomY:cin D were
designed to see whether or not the effect produced by the Vitamin within this time interval could be blocked by the antibiotic.

This informa-

tion would reveal whether or not the action of the vitamin was directed
upon the nuclear chromatin material of the rachitic bone cells.
At 5:00 A. M. on the day of the experiment, the animals were
divided into four groups of four animals each, such that a dose of 100 µg
of achnomycin D or its vehicle
was injected
intraperitoneally two hours
.
.
prior to the administration of either vitamin D
vehicle.

3

( 5000 I. U.). or its

Seven hours after the administration of the vitamin or vehicle

all animals received 50 µc of

3

H-orotic acid and two hours later they

were sacrificed.
The data in Table ViII and Table IX again indicate that there was

- 61 -

TABLE VII
INFLUENCE OF 5000 I. U. OF VITAMIN
OF

3

o ON THE INCORPORATION
3

H-0ROTIC ACID INTO RNA OF RACHITIC RAT BONE*

Specific Activity of

3

H-RNA

(dpm/mg R:NA)
Experiment No.

Control

2

+
2920 - 88

Vitamin 03
+
3960 - 119

5

+
2640 - 19

+
2790 -

84

6

+
f 600 - 48

+
2370 -

71

7

+
1920 - 58

+
3340 - 100

8

+
2250 - 68

+
3200 -

2266

*Vitamin o 3

!

68**

3f 32

!

96
94 **

deficient rats maintained on a diet with a high Ca:P

ratio were sacrificed 9 hours after having received 5000 I. U. of
vitamin
3

.o 3

·or vehicle intraperitoneally.

H-orotic acid 2 hours before sacrifice.

All rats received 50 µc of
The specific activity of

labeled RNA was determined for each experiment on pooled samples
of bone obtained from 4 or 5 animals.
**Mean - 3% counting error.
cant at P

=

O. 05.

The difference between means is signifi-
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TABLE VITI
EFFECT OF ACTINOMYCIN DON VITAMIN D
STIMULATED INCORPORATION OF

3

3

H-OROTIC

ACID INTO RNA OF RACHITIC RAT BONE*

Specific Activity of

Treatment
Actinomycin D

Vitamin D

3

H-RNA
( dpm I mg RNA) **
1540

+

*Vitamin

"t

46

+

2020 - 60
300 +

+

+

+
D

3

3

9

+

460 - 13

deficient rats maintained on a diet with a high Ca:P

ratio were given 100 µg of actinomycin D or a control solution.
Two hours later they were given 5000 I. U. of vitamin D
intraperitoneally.

Each animal received 50 µc of

3

3

or vehicle

H-orotic acid

seven hours after vitamin D3 or vehicle ·and all were ·sacrificed two
hours later.

The specific activity of the labeled RNA was determined

on pooled samples of bone obtained from 4 animals given the treat-·
ment specified.
**Specific activity +
- 3% counting error.
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TABLE IX
EFFECT OF ACTINOMYCIN DON VITAMIN D
STIMULA.TED INCORPORATION OF

3

3

H-OROTIC

ACID INTO RNA OF RACHITIC RAT BONE*

Specific Activity of

Treatment
Vitamin

Actinomycin D

3

H-RNA

(dpm/mg RNA) *

o3

+

2030 - 60
2310 :: 69

+

+

561 - 16

+

*Vitamin o 3

836 :: 25

+

+

deficient rats maintained on a diet with a high Ca:P

ratio were given 100 µg of actinomycin D or a control vehicle.
Two hours later they were given 5000 I. U. of vitamin
intraperitoneally.

Each animal received 50 µc of

seven hours. after vitamin
hours later.

o3

3

o3

or vehicle

H-orotic acid

or vehicle and all were sacrificed two

The specific activity of the labeled RNA was deter-

mined on pooled samples of bone obtained from 4 animals given the .
treatment specified.
**.
+.
Specific activity - 3% counting error.

- 64 of
the

dministration of vitamin

any actinomycin D.

H-orotic acid into RNA nine hours after

o3

in those animals that did not receive

That actinomycin O was effective in decreasing
3

the incorporation of
specific activity of

3

3

H-orotic acid is evidenced

~y

the decrease in

H-RNA upon prior administration of the antibiotic.

However, the results also show that the stimulatory effect of the
vitamin could not be blocked even upon prior treatment of animals with
I

actinorhycin 0.

The specific activities of the tritiated RNA from the

1

vitamin-treated animals, instead of being the same, were still higher
than those from the control animals.

This would imply that the action

of the vitamin is probably not on the nuclear chromatin material.

Experiment 11:

Effect of Vitamin

o3

on the Incorporation of

3

H-Uridine

into RNA of Rachitic Rat Bone.
This experiment was performed to see whether or not vitamin
induced the stimulate<:! incorporation of
3

H--orotic acid, into RNA.

3

o3

H-uridine, in addition to that of

Also, actinomycin 0 was ei:nployed to

determine whether or not the stimulatory action of the vitamin could be
blocked, in the event that such an effect was produced.
Rachitic rats were fasted 15 hours before the experiment which
began at 5:00 A. M.

·The ·animals were divided into four groups of

- 65 four animals each and received 100 µg of actinomycin D or vehicle 2
hour

before the administration of 5000 I. U. of

hour~

after the injection of vitamin

n3

or vehicle.

Seven

n 3 or vehicle. all animals received

'50 µc of 3H-uridine and 2 hours later the animals were sacrificed.
bones were removed and

3

H-RNA extracted as previously described.

The results in Table X indicate that vitamin n
the incorporation of

3

The

3

does stimulate

H-uridine into RNA of rachitic rat bone.

However.

the data observed with actinomycin D support the results obtained
J

previously that the antibiotic did not block the enhanced incorporation of
3 a-orotic acid into RNA.

Of interest. in addition, is the fact that

the specific activities reported in Table X for control and D -treated
3
animals without prior administration of actinomycin D are smaller than
those reported in Tables VIII and IX when the isotope
was employed instead of

3

H -uridine.

3

H-orotic acid
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TABLE X
EFFECT OF ACTINOMYCIN D ON VITAMIN.

'

STIMULATED INCORPORATION OF

3

o

3

H- URIDINE

INTO RNA OF RACHITIC RAT BONE*

Treatment
Actinomycin D

Specific Activity of

Vitamin

o3

3

H-RNA
(dpm/mg RNA} **

+

639 - 19

+

896 + 26

+

+

219 -

+

+

*Vitamin o 3

6

+
338 - 10

deficient rats maintained on a diet with a high Ca:P

ratiO were given 100 µg of actinomycin D or a control solution.
Two hours later they were given 5000 I. U. of vitamin
intraperitoneally.

Each animal received 50 µc of

3

o3

or vehicle

H-uridine seven

hours after .vitamin 03 or vehicle and all were·· sacrificed two. ho"urs
later.

The specific activity of the labeled RNA was determined on

pooled samples of bone obtained from 4 animals given the treatment
specified.
*~

+

...Specific activity - 3% c.ounti~g error.
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DISCUSSION AND CONCLUSIONS
The physiological expression of vitamin D action in skeletal tissue
results in accretion.

The biochemical events occurring after the ad-

ministration of the vitamin and prior to accretion have not been
delineated.

In contrast to its action in intestine, it has not been

demon~trated

whether or not the vitamin can induce protein synthesis in

I

1

bone, although recent work by Canas et al. ( 8) suggests that thfs may
be the case.
Administration of 2000 I. U. of vitamin D
rats stimulates the incorporation of

3

3

intraperitoneally to

H-orotic acid into RNA obtained

from the mucosa! cells of intestinal tissue (53).
by prior administration of actinomycin D.

This effect is blocked

The metabolic inhibitor is

believed to exert its effect by combining with the guanine moieties of
DNA.

The accepted concept for its mode of action is that it blocks

DNA-directed synthesiii of m-RNA.

Ther.efore., the._ results reported by

Stohs et al. ( 53) strongly suggest that the action o! the vitamin may be ·
on the DNA - m-RNA complex of intestinal mucosa! cells.
Such a proposal for the action of vitamin D on bone has not been
suggested.

However, since bone and intestine are target organs for

the vitamin, a reasonable hypothesis would be that the vitamin may

- 68 act in a manner similar to its action in the intestine and stimulate the
rapic labeling of skeletal tissue RNA by a precursor such as
acid.

3

H-orotic

This has now been demonstrated.
Care was taken in these experiments in the ·isolation of the RNA

before it was counted for tritium content.

The RNA was extracted

initially from skeletal tissue with perchloric acid followed by extraction
with phenol.

The RNA was then freed from any contamination with

phenol.by passing it through a column of Sephadex G-25 (Figure 2).

.

I

That RNA was really isolated is shown first by the ultraviolet spectra,
routinely checked, (Figure 3) and by hydrolysis of the RNA with
subsequent isolation of the pyrimidine mononucleotide UMP (Figures 7
and 8).
From Table VI and Figure 9 it can be seen that an early event
in the action of vitamin

o

3

is an increased synthesis of RNA in the

skeletal tissue of rachitic 'rats.

A maximal response is obtained 9

hours after the intraperitoneal administration of 5000 I. U. of the
.
vitamin and this response is significant at P . = O. 05 (T-e.ble :VII).
Various interpretations may be advanced to account for the decrease
in specific activity observed twelve hours after the administration of
vitamin

o3

and illustrated in Figure 9.

It has been reported that upon

3
the intravenous injection of 10 I. U. of 1, 2- H-vitamin

o3

(10 I. U., or

- 69 O. 25 µg, is considered to be a physiological dose for the rat) 24 per
cent of the original dose still remained in the plasma of rats after 6
hours and this amqunt was essentially the same even after 12 hours
113).

Also, 10 per cent of the original dose could be found in the

skeleton 4 hours after the administration of the vitamin; the time study
did not exceed 4 hours.

In the experiments reported here no attempt

was made to determine the effective concentration of vitamin
cells.

o3

in bone

However, although the route of injection was different (intra-

peritoneal versus intravenous). the administration of 5000 I. U. of
vitamin

o3

makes it seem unlikely that the concentration of the vitamin

present in skeletal tissue is not . sufficient to produce an effect even
after 12 hours.
As previously mentioned, vitamin
the incorporation of

3

o3

has been shown to stimulate

H-orotic acid into RNA of intestinal mucosa! cells.

In that study Stohs et al. ( 53) demonstrated that the stimulatory effect
produced by the vitamin was abolished after 8 hours.

They. proposed

that the decrease in th~ J;'esponse may have resvlted from an increase
in the level of intracellular calcium with the cation subsequently acting
as a feedback inhibitor. blocking the synthesis of more RNA following ·
the initial burst.

Since bone and intestine are target tissues for the

vitamin, the idea that some regulatory mechanism may also exit in

- 70 skel~

tal tissue that controls the action of vitamin

o3

cannot be dis_

miss~d.

Finally. depletion of the RNA precursor

3
H -orotic acid following

i

the initial increase in RNA synthesis may be an additional explanation
for the decrease in specific activity observed 12 hours after the administration of vitamin

o3.

Figure 9 illustrates that there is an increase in the rate of RNA
synthesis at 3. 6 and 9 hours following the administration of 5000 I. U.
.

I

i

of vitamin
activity of

o3
3

intraperitoneally.

However. this increase in specific

H-RNA with time is paralleled by a similar increase.

aithough of smaller magnitude. in the control animals.

A possible

explanation for this may arise upon closer examination of the vehicle
utilized for these experiments.

The solution containing vitamin

o was
3

prepared by first dissolving 5 milligrams of the vitamin in 0. 5 ml of
95% ethanol and then diluting this solution to 10 ml with propylene
glycol such that O. 25 ml of this solution was equivalent to 5000 I. U.
Oxidation of one of the components in the vehicle namely. propylene
glycol, results in the production of lactic and pyruvic acids.

The

rachitic rats used in these experiments were fasted approximately 15
hours before the start of each experiment.
exists that propylene

glyc~l.

Therefore. the possibility

and more specifically its metabolites. may
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have served as a source of food for these animals.

The incorporation

of these metabolites into the general metabolism of bone cells may
have favored an increase in the rate of RNA synthesis.
an effect, in addition to that of vitamin

o 3,

Consequently,

may· have been produced

because of the vehicle employed.
In addition to propylene glycol, the use of ethanol in the vehicle
merits consideration.
fate of vitamin

o3

Recently, Ponchow et al. (45) have studied the

in vitamin 0-deficient rats following the intravenous

3
injection of 10 I. U. of 1, 2- H-vitamin

o 3 dissolved either in O. 05 ml

of absolute ethanol or O. O5 ml of blood plasma.

Thefr study revealed

that ethanol accelerates the disappearance of vitamin

o3

from the

plasma and that this disappearance may have been reflected in the observed increased fecal excretion of tritium in the ethanol-treated rats.
Also, they proposed that ethanol may interfere directly with the intracellular metabolism of the vitamin in the liver by decreasing the rate
of conversion of vitamin
· -ciferol.

3

In the current experiments the route: of administration and the

dose of vitamin
(45).

o to its active metabolite 25-hydroxycholecal-

o 3 were different from those utilized by Ponchow et al.

Also, approximately O. 01 ml of ethanol (as compared to O. 05 ml

reported above) was contained in O. 25 ml of the injection medium. ·
Therefore, although it is possible, it seems unlikely that this amount

- 72 of ethanol administered intraperitoneally along with 5000 I. U. of
vitamin

o3

would have any noticeable effect on the metabolism of the

vitamin in these experiments.

·'

From Tables VIII and IX it appears that the stimulated incorpora-

tion of
vitamin

3

H-orotic acid into RNA nine hours after the administration of

o3

is not abolished by prior administration of actinomycin O.

This suggests that the vitamin may act in some fashion other than
directly upon the nuclear chromatin material.
suggest that vitamin

o3

There is evidence to

acts on cellular membranes of intestinal

mucosa! cells (25, 27, 67) as well as on the subcellular· membranes of
the nucleus (52) and mitochondria (12).

This is in contrast to the

apparent action of the vitamin on the nuclear chromatin material (23,
28, 29).

Therefore. the vitamin may well exhibit multiple sites of

action.

If this is the case. then one may postulate that vitamin 0 may

act analogously to its action in the intestine and alter the membrane
permeability of skeletal tissue cells.

This could ultimately result in an

increase in the availability of the: RNA precursor

3

H-orotic :;i.cid. and

this increase may be reflected in a greater incorporation of the isotope
into RNA.
Upon histochemical examination of skeletal tissue obtained from
normal and rachitic rats, it has been observed that the activity of
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certain enzymes was altered following the administration of vitamin D
(Z. 14, 15, 17).

However. these studies did not reveal whether or not

the vitamin acted directly upon a particular enzymatic reaction or
j.ndirectly by affecting the synthesis of the enzyme.

If the vitamin can

affect enzyme reactions of skeletal tissue directly, then it is possible
to assume that the vitamin may increase the synthesis of RNA in bone
indirectly by stimulating the activity of an enzyme such as DNAdependent RNA polymerase.

Such a stimulation has actually been

demonstrated (54) in the case of several hormones (e.g .• thyroid
hormone. growth hormone, testosterone).

However, the mechanism of

the stimulatory action of these hormones on the RNA polymerase is
not known.
The dose of 5000 I. U. of vitamin

o3

used in the above experi-

ments is several orders of magnitude larger than that considered to be
a physiological dose (10 I. U.) for the rat.

However, this is not to say

that the response obtained (i.e.. an increase in the rate of RNA
synthesis). is an _apparent dissociation .from the physiological actio!l of
the vitamin.

It is probable that such a dose of the vitamin may have

partially overcome the inhibition by actinomycin D.

That this may be.

the case is suggested by studies of certain hormones, in which it was
reported that an increase in the dose of a hormone partially overcame
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prior inhibition by actinomycin O (54).
Table X shows that vitamin
3

o3

stimulated the incorporation of

H-ur>idine into RNA in those animals that had not been previously

Freated with actinomycin 0.

In addition, the stimulatory action of the

vitamin was still observed upon treatment of the animals with
actinomycin 0 prior to the administration of vitamin

o 3.

Therefore,

it appears that the action of the vitamin is not on the nuclear chromatin
material.

o3

Several explanations are possible for the action of vitamin

!

and these are the same as those mentioned above relative to the

experiments in which

3

.

>

H-orotic acid was used instead. of

3

H-uridine.

Of interest, also, is the fact that the specific activities reported in
Table X for control and

o 3 -treated

animals without prior administration

of actinomycin 0., are smaller than those reported in Tables VIII and
IX when

3

H-orotic acid was employed instead of

3

H-uridine.

Examina-

tion of possible pathways for the enzymatic synthesis of pyrimidines 11ot
involving' orotic acid, has revealed that isotopic uridine serves as a
poor substrate for the synthesis. of. UMP
decrease in the utilization
(4 7).

In the above

of

i~

mammals as evidence,fl by. a

the isotope for polyi:mcleotide synthesis

exp~riments the 3H-orotic acid or 3H-uridine was

administered two hours prior to sacrifice.

Since uridine is not the

substrate of choice in the synthesis of UMP, a possible explanation for
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the Jiower specific activities reported in Table X would be that the

conv~ rsion of 3H-uridine to 3H- UMP requires a pulse labeling period

longe~
that

than two hours to produce an amount of

~ormed

when

3

3

H- UMP equivalent to

H-orotic acid is used as a precursor instead.

In this study no attempt was made to distinguish between the

various types of RNA isolated from the bone of rachitic animals.
ever, the evidence suggests that vitamin
of

m-~NA

o3

How-

does not affect the synthesis

directly even though the overall rate of RNA synthesis was

i

increased.

Nevertheless, it is still possible that the vitamin may have

acted at the nuclear level indirectly by stimulating the· activity of an
enzyme(s) essential for the synthesis of m- RNA or by altering nuclear
membrane permeability such that the precursors for RNA synthesis
are more readily available.

At present it is difficult to discern the

full importance of this stimulation in the sequence of events which occurs
following the administration of vitamin o .
3

It does seem, however,

that an early event in the expression of vitamin

o3

action in rachitic

. bone involv.es the increase in the rate- of RNA· synthesis. -

I

•
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ABSTRACT
Abstract of the dissertation entitled "THE EFFECT OF VITAMIN
D

3

ON THE INCORPORATION OF

3

H-OROTIC ACID INTO RIBONUCLEIC

ACID OF RAT BONE" submitted by Rodger S. Izzo in partial fulfillment
of the requirements for the degree of Doctor of Philosophy, February,
1970.
The effect of vitamin D

3

on the incorporation of

3

H-orotic acid into

the RNA of bone obtained from rachitic rats was determined.

Rickets

was produced in young animals by maintaining them for four weeks on a
diet containing a high Ca:P ratio a:od deficient in vitamin D .
3

Reduced

growth and an elevation in the level of serum alkaline phosphatase were
used as parameters to establish that the rats were rachitic.
The administration of 5000 I. U. of vitamin D

3

intraperitoneally to

rachitic animals, previously fasted for 15 hours, was followed by
sacrifice at 3, 6,, 9, 12 and 15 hours.
all animals received 50 µc of

3

Two hours prior to sacrifice

H-orotic acid.

The femurs, tibiae and

humeri were removed from each animal and the RNA was extracted.
Care was taken in these experiments in the isolation of the RNA
before it was counted for tritium content.·

The RNA was extracted

initially from skeletal tissue with perchloric acid followed by extraction
with phenol.

The RNA was then freed from any contamination with

phenol by passing it through a ·column of Sephadex G-25.

That RNA

was really isolated was shown first by the ultraviolet spectra, routinely
checked, and by the hydrolysis of the RNA with subsequent isolation of
the pyrimidine mononucleotide UMP.
At all time intervals studied, treatment with vitamin D
the incorporation of

3

3

increased

H-orotic acid into the ribonucleic acid of rachitic

bone with a maximal response being observed by the ninth hour.

Prior

treatment of the animals with an antibiotic, actinomycin D. did not
abolish the stimulatory action of vitamin
3

H-uridine instead of

3

n3.

In a similar study utilizing

H-orotic aci?• it was found that vitamin

n3

stimulated the incorporation of the isotope into the RNA of bone.

Again,

as was reported above, prior administration of actinomycin D did not
abolish the stimulatory effect of the vitamin.

This would suggest that

the action of the vitamin is not on the nuclear chromatin material.
At present it is difficult to discern the full importance of this
stimulation in the sequence of events which occurs following the
administration of

vita~in

n3.

It does seem, however, that an early

event in the expression of vitamin

n 3 action in the bone of rachitic

animals involves the increase in the rate of RNA synthesis.
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